Varlilumab: A Deep Dive into CDX-1127 and its Mechanism The antibody (formerly known as compound CDX-1127) represents a promising immunotherapeutic agent targeting this surface receptor. The drug's function depends on https://www.targetmol.com/compound/varlilumab